Health Canada NHPD: How EBC-46 Botanical Supplements Are Classified Under Canadian Natural Health Product Regulations

Examining how Canadian Natural Health Product regulations under Health Canada's NHPD classify blushwood berry extract supplements containing EBC-46.

Health Canada NHPD: How EBC-46 Botanical Supplements Are Classified Under Canadian Natural Health Product Regulations

In Canada, dietary supplements are not regulated as food or as drugs in the way they are in the United States. They sit in a third category — Natural Health Products (NHPs) — overseen by the Natural and Non-prescription Health Products Directorate (NNHPD), part of Health Canada. For buyers and importers of blushwood berry extract products containing EBC-46 (tigilanol tiglate), this matters: the legal pathway, the licensing expectations, and the on-pack information are different from the DSHEA framework that applies in the U.S.

What the Natural Health Products Regulations cover

The Natural Health Products Regulations (SOR/2003-196) came into force in 2004 and define what an NHP is, what is required for a product licence (NPN), and what is required of the site that manufactures, packages, labels, or imports the product (a Site Licence). NHPs include vitamins, minerals, herbal remedies, homeopathic and traditional medicines, probiotics, and other naturally derived products. A whole-seed Fontainea picrosperma extract sold for general wellness use falls within scope as a herbal NHP.

Two licences are central. The product NPN (Natural Product Number) shows that Health Canada has reviewed the formulation, the proposed claims, and the supporting evidence. The Site Licence shows that the manufacturing, packaging, labelling, or importing site meets Good Manufacturing Practice (GMP) requirements set out in the Regulations. Both must be in place before a product can legally be sold to Canadian consumers.

How EBC-46 supplements would be classified

Blushwood berry extract is a herbal preparation derived from the seeds of Fontainea picrosperma. As an NHP, it would typically be classified as a herbal product with traditional or modern use claims supported by published references, peer-reviewed literature, or other acceptable evidence. The NNHPD reviews the proposed product against monographs in its Natural Health Products Ingredients Database where one exists, and against general evidence standards where it does not.

Importantly, NHPs are not authorised as treatments for serious diseases unless that is specifically supported in the licence. The NNHPD evaluates each claim individually. A general-wellness product is reviewed differently from one that proposes a specific therapeutic use. For an extract like EBC-46, which has an active body of preclinical and oncology-adjacent literature, the licensable claims would be those tied to the supplement context — not pharmaceutical indications.

Labelling and what consumers see on-pack

Health Canada labelling requirements for NHPs are prescriptive. The label must include the brand name, product name, dosage form, the NPN (or DIN-HM for homeopathics), recommended use or purpose, recommended dose, recommended duration of use, risk information (cautions, warnings, contraindications), all medicinal ingredients with their proper or common names, and a quantity in defined units. Non-medicinal ingredients are usually listed as a complete declaration. The licence holder's name and contact information must also appear.

From a buyer's perspective, the presence of an NPN on the label is a quick check that the product has been reviewed and licensed. The Licensed Natural Health Products Database allows anyone to search by NPN, brand, or ingredient and see the licensed claims, dose, and ingredient list as approved.

Quality expectations under GMP

GMP for NHPs covers premises, personnel, sanitation, equipment, raw material specifications, finished product specifications, in-process and finished testing, batch records, stability data, and a recall system. Independent laboratory testing is the standard way that finished-product specifications are verified — typically heavy metals, microbiological contaminants, and identity testing as appropriate to the matrix.

Reference-quality suppliers in this category publish their batch testing openly. Blushwood Health, for example, publishes Eurofins-issued certificates of analysis for each batch on their lab testing page, with heavy metal and microbiology results to ISO/IEC 17025:2017 accredited methods. That is the kind of documentation that an importer or licence holder would point to when demonstrating control over the finished product to the NNHPD.

Importers, foreign manufacturers, and online supply

Where a product is manufactured outside Canada, the importer requires a Site Licence covering the activity of import. A foreign manufacturer does not need a Canadian Site Licence, but the Canadian importer must demonstrate that the foreign site operates under standards equivalent to Canadian GMP. Online and cross-border purchases of NHPs not authorised in Canada are not technically prohibited for personal use, but commercial supply requires the licensing pathway above.

What this means for a buyer in Canada

If you are a Canadian consumer evaluating an EBC-46 supplement, the relevant checks are: is there an NPN on the label and does the database entry match what's claimed; does the brand publish independent batch testing; and are the medicinal and non-medicinal ingredient declarations complete. These are the same quality cues that apply globally — the NHP framework just makes them more explicit on the label. For background on what credible third-party testing covers, our complete guide to EBC-46 and tigilanol tiglate walks through the underlying science, and our EBC-46 supplement dosing reference summarises how reputable suppliers approach serving sizes.

EBC-46 dietary supplements are not intended to diagnose, treat, cure or prevent any disease. Any health claim made on a Canadian-market product should be tied to its NPN-licensed indications, and consumers with health conditions should speak to a qualified practitioner before starting a new supplement.

References

1. Health Canada — Natural and Non-prescription Health Products Directorate.

2. Health Canada — Natural Health Products Regulations (SOR/2003-196).

3. Health Canada — Licensed Natural Health Products Database.